z-logo
open-access-imgOpen Access
Prognostic Significance of Immunohistochemical Epithelial–Mesenchymal Transition Markers in Skin Melanoma Patients
Author(s) -
Małgorzata Pieniążek,
Piotr Donizy,
Agnieszka Hałoń,
Marek Leskiewicz,
Rafał Matkowski
Publication year - 2016
Publication title -
biomarkers in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.652
H-Index - 44
eISSN - 1752-0371
pISSN - 1752-0363
DOI - 10.2217/bmm-2016-0133
Subject(s) - medicine , melanoma , immunochemistry , epithelial–mesenchymal transition , immunohistochemistry , proportional hazards model , pathology , oncology , mesenchymal stem cell , nodal , clinical significance , univariate analysis , transition (genetics) , cancer research , multivariate analysis , cancer , metastasis , antibody , biology , immunology , gene , biochemistry
Aim: To investigate secreted protein acidic and rich in cystein (SPARC) and neural cadherin (NCAD), which are associated with epithelial–mesenchymal transition in primary skin melanoma and nodal metastases and their prognostic impact in melanoma patients. Methods: Expression of proteins was assessed by immunochemistry in archival paraffin samples from 103 primary melanoma tumors and 16 nodal metastases. Results: Increased expression of SPARC and NCAD in primary skin melanoma was associated with decreased overall survival, adverse clinicopathological features and particularly with microsatellitosis (SPARC) and ulceration (NCAD). In univariate Cox regression analysis, both biomarkers were significantly associated with the risk of death; the multivariate Cox regression analysis identified no significance. Conclusion: The most important result of our study was that we confirmed the strict correlation between SPARC and NCAD expression and clinicopathological parameters related with melanoma progression, which is a specific clinical equivalent of the molecular mechanisms of epithelial–mesenchymal transition process and confirms its key role in the disease outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom